Contact us
Back to top

HealthDay Reports: What If a COVID-19 Vaccine Arrived and Many Americans Said No?

Exactly how Americans will greet a COVID-19 vaccine is unknown, but polls have suggested many will be wary. In an Associated Press survey in late May, only half of respondents said they would get vaccinated.

What If a COVID-19 Vaccine Arrived and Many Americans Said No?

TUESDAY, July 14, 2020 (HealthDay News) -- With several potential COVID-19 vaccines now in clinical trials, U.S. policymakers need to plan for the next hurdle: Ensuring Americans actually get vaccinated.

That's according to a new report from the Johns Hopkins Center for Health Security. It lays out recommendations for winning the public's trust of any future vaccine, and helping them access it as easily as possible.

The U.S. government's so-called Operation Warp Speed has laid its goal out: Deliver 300 million doses of a safe, effective COVID-19 vaccine by January 2021.

Read the full HealthDay story.

HealthDay Reports: In Early Trial, an Ancient Drug Shows Promise Against Severe COVID-19

The drug is an anti-inflammatory that has been prescribed for gout, but there's evidence the medicine could help fight against COVID-19.

In Early Trial, an Ancient Drug Shows Promise Against Severe COVID-19

WEDNESDAY, June 24, 2020 (HealthDay News) -- There's new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19.

The medication, called colchicine, is an anti-inflammatory taken as a pill. It's long been prescribed for gout, a form of arthritis, and its history goes back centuries. The drug was first sourced from the autumn crocus flower.

Doctors also sometimes use colchicine to treat pericarditis, where the sac around the heart becomes inflamed.

Read the full HealthDay story.

HealthDay Reports: Love During Lockdown — Survey Shows How Couples Have Coped

From arguments and friction to sex and affection, see how the recent stay-at-home lockdowns have affected couples across the country.

Love During Lockdown: Survey Shows How Couples Have Coped

THURSDAY, June 11, 2020 (HealthDay News) -- As U.S. states issued stay-at-home orders in March and April, one of many questions was how couples would fare under lockdown together. Now a new survey offers an initial snapshot: some more arguments, regular declarations of love, and a good dose of same-old, same-old.

The survey included close to 2,300 U.S. adults who were living with their partner when the pandemic hit -- forcing most to hunker down at home.

For some couples, the extra together time caused friction: One-quarter of respondents admitted to more arguments with their partner.

Read the full HealthDay story.

HealthDay Reports: Fewer Suicide-Related ER Visits in COVID Era, and That Has Experts Worried

A new study warns that the COVID-19 pandemic may be keeping people from seeking help for suicidal thoughts.

Fewer Suicide-Related ER Visits in COVID Era, and That Has Experts Worried

MONDAY, June 8, 2020 (HealthDay News) -- The COVID-19 pandemic has had far-reaching effects, and a new study points to yet another: It may be keeping people from seeking emergency care for suicidal thoughts.

The study, at one large Ohio health system, found that ER visits for suicidal ideation dropped by over 60% in the month after the state instituted its stay-at-home order.

And that's concerning, researchers said, because, if anything, this is a time when mental health needs are expected to be more acute than ever.

Read the full HealthDay story.

HealthDay Reports: Loss of Smell, Taste Might Be Long-Term for Some COVID-19 Survivors

One symptom of COVID-19 is the loss of smell or taste, and doctors worry it might be permanent in a small number of people who experience it.

Loss of Smell, Taste Might Be Long-Term for Some COVID-19 Survivors

THURSDAY, June 4, 2020 (HealthDay News) -- Since the start of the COVID-19 pandemic, it's become clear that many people with the infection lose their sense of smell and taste. And doctors are concerned that some will never get back to normal.

At this point, it's hard to know how common the symptom is. First, there were anecdotal reports of COVID-19 patients who had lost their ability to smell or taste, said Dr. Nicholas Rowan, an assistant professor of otolaryngology-head and neck surgery at Johns Hopkins University in Baltimore.

And then, he said, studies started to confirm "there's a lot of truth to it."

Read the full HealthDay story.

HealthDay Reports: Last Year's NYC Measles Outbreak Has Lessons for COVID Crisis

A measles outbreak in New York City last year that sickened 649 people could provide clues on how to respond to the current COVID-19 pandemic.

Last Year's NYC Measles Outbreak Has Lessons for COVID Crisis

TUESDAY, June 2, 2020 (HealthDay News) -- In a finding that could help guide the response to the coronavirus pandemic, new research shows that a measles outbreak that struck New York City last year could have been much worse if the city had not launched a vaccine campaign.

The measles outbreak -- the largest in the United States in nearly three decades -- ultimately sickened 649 people. Most were children in a Brooklyn Orthodox Jewish community.

It all began fall of 2018 when an unvaccinated child returned home from a trip to Israel infected with the measles virus. Low vaccination rates in the local Orthodox community allowed the infection to spread.

Read the full HealthDay story.

HealthDay Reports: Lockdown Got You Feeling Low? Yoga May Help

A new research review suggests that yoga can help ease depression symptoms.

Lockdown Got You Feeling Low? Yoga May Help

THURSDAY, May 21, 2020 (HealthDay News) -- Many people under stay-at-home orders have turned to online yoga as a way to manage the stress. And a new research review suggests they're onto something.

The review, of 19 clinical trials, focused on the benefits of yoga for people with clinical mental health conditions ranging from anxiety disorders to alcohol dependence to schizophrenia. Overall, it found yoga classes helped ease those patients' depression symptoms.

And while the trials focused on in-person classes for people with formal diagnoses, there are broader implications, the researchers said.

Read the full HealthDay story.

HealthDay Reports: Can Survivors Get Reinfected With Coronavirus?

Though research on reinfection of COVID-19 specifically isn't available because it's still so new, one study took a look at if people who've had other coronaviruses and recovered are immune to them afterward.

Can Survivors Get Reinfected With Coronavirus?

MONDAY, May 4, 2020 (HealthDay News) -- People all over the globe who've recovered from the new coronavirus want to know the same thing: Am I immune, at least for a while? A new study of common coronaviruses is not exactly reassuring.

Researchers found it was "not uncommon" for people with run-of-the-mill coronaviruses (not the one that causes COVID-19) to have a repeat infection within a year. Of 86 New York City residents infected with those coronaviruses, 12 tested positive for the same bug again.

A big caveat is, the study looked only at the four coronaviruses that are endemic in humans -- the kind that cause nothing worse than cold symptoms.

"They're kind of wimpy," said researcher Jeffrey Shaman, a professor of environmental health sciences at Columbia University Mailman School of Public Health. "People rarely have to go to the doctor for these infections."

So it's hard to know, Shaman said, whether our experiences with endemic coronaviruses will translate to SARS-CoV-2 -- the coronavirus that causes COVID-19.

"It's not the same as these endemic viruses," Shaman said. "But obviously, we can't look at repeat infections with [SARS-CoV-2], because it's new."

In lieu of that, he said, analyzing the patterns of regular coronaviruses -- how often reinfections occur, and in what time frame -- may at least give a sense of what could happen with the new virus.

Read the full HealthDay story.

Most Popular

HealthDay Now: Experts Weigh In On Alzheimer's Drug Controversy

HealthDay Now: Diabetes Care in 2021

HealthDay Now: Cancer Experts Share Highlights From Two Conferences

Latest

HealthDay Reports: Could an Ancient Drug Help Fight Severe COVID-19?

HealthDay Reports: COVID-19 Can Trigger Serious Heart Injuries

HealthDay Reports: Trials Begin for Potential COVID-19 Drug Remdesivir

HealthDay Reports: Severe COVID-19 May Hurt the Heart